Atul Varadhachary Ph.D Overview
- Company
- Radiomer Therape...
- Primary Position
-
Chief Executive...
- Primary Industry
-
Healthcare
- Active Board Seats
-
5
- Med. Deal Size
-
- Med. Valuation
-
Atul Varadhachary Ph.D General Information
Biography
Dr. Atul Varadhachary serves as Chief Executive Officer & Board Member at Radiomer Therapeutics. He serves as President and Chief Executive Officer at Allterum Therapeutics. He also serves as a Managing Partner at Fannin Partners, the parent company of Radiomer Therapeutics. He serves as a Board Member at Pulmotect, Inc., Brevitest, Inc., Goldenrod Therapeutics, and Raptamer Discovery Group. Before Fannin, he was President of U.S. Operations at Reliance Life Sciences, part of the Reliance Group, India's largest corporation. He served nine years as President & COO of Agennix, Inc., a late-stage biotechnology company. As product development and regulatory lead, he helped advance Agennix's lead molecule from preclinical studies into pivotal Phase 3 human studies and led a successful sale of the company. Before Agennix, he was Senior Engagement Manager at McKinsey & Co. where he co-led initiatives to support life science commercialization at Houston's Texas Medical Center. He co-founded and ran Pratham Health (now the Niramaya Health Foundation), a preventive health program reaching 65,000 under-served preschool children in India while on leave of absence from McKinsey. He was a Pratham USA founding director and past President. He is active in Houston's biotech and commercialization ecosystem. He has served as an Adjunct Professor at Rice University, Baylor College of Medicine, and the UT School of Public Health, and on several companies and community Boards, including Houston, the Harris Health System, TiE Houston, and the Indo-American Chamber of Commerce of Greater Houston (IACCGH) where he also served as President. He serves on the Greater Houston Partnership's Healthcare Advisory Committee and on the Jones Health Care Advisory Board. He received his medical training at the University of Bombay. He earned a Ph.D. in Physiology, followed by a postdoctoral fellowship in Biological Chemistry, both at Johns Hopkins School of Medicine, where he was the founding President of the Johns Hopkins Postdoctoral Association, the first such organization in the country.
Contact Information
Address
- 3900 Essex Lane
- Suite 575
- Houston, TX 77027
- United States
Atul Varadhachary Ph.D Positions (6)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
ACF Pharmaceuticals | Company | President | Houston, TX | Biotechnology | |
Allterum Therapeutics | Company | President & Chief Executive Officer | Houston, TX | Drug Discovery | |
ATCG | Company | Chief Executive Officer | Houston, TX | Other Pharmaceuticals and Biotechnology | |
Brevitest | Company | Co-Founder & Board Member | Houston, TX | Diagnostic Equipment | |
Fannin Innovation Studio | Investor | Managing Partner & Board Member | Houston, TX | Venture Capital |
Atul Varadhachary Ph.D Board Seats (5)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Brevitest | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Houston, TX | |
Brimstalt Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Houston, TX | |
Fannin Innovation Studio | Other Commercial Services | Privately Held (backing) | Venture Capital-Backed | Houston, TX | |
Goldenrod Therapeutics | Drug Discovery | Privately Held (no backing) | Corporation | Houston, TX | |
Radiomer Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Houston, TX |
Atul Varadhachary Ph.D Lead Partner on Deals (4)
Atul Varadhachary Ph.D has been the lead partner on 4 deals. Their latest deal was with Pulmotect, a biotechnology company. The deal was made for on 19-Feb-2020.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Pulmotect | 19-Feb-2020 | Later Stage VC (Series B) | Completed | Biotechnology | Houston, TX | |
Pulmotect | 14-Apr-2016 | Completed | Biotechnology | Houston, TX | ||
Pulmotect | 01-Aug-2008 | Corporate | Completed | Biotechnology | Houston, TX | |
Brimstalt Therapeutics | Seed Round | Completed | Drug Discovery | Houston, TX |
Atul Varadhachary Ph.D Network (13)
Board Members (8)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Magnus Höök Ph.D | Pulmotect | Pulmotect | Houston, TX | |
Colin Broom MD | Pulmotect | Self | Houston, TX | |
Pulmotect | Self | Houston, TX | ||
Pulmotect | Fannin Innovation Studio | Houston, TX | ||
Brevitest | Self | Houston, TX |
Portfolio Executives (5)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Colin Broom MD | Pulmotect | Chief Executive Officer & Board Member | 19-Feb-2020 | Houston, TX |
Magnus Höök Ph.D | Pulmotect | Co-Founder & Board Member | 19-Feb-2020 | Houston, TX |
Pulmotect | Co-Founder & Scientific Advisor | 19-Feb-2020 | Houston, TX | |
Pulmotect | Co-Founder, Chief Operating Officer, Board Member & President | 19-Feb-2020 | Houston, TX | |
Pulmotect | Chief Financial Officer | 19-Feb-2020 | Houston, TX |
Atul Varadhachary Ph.D FAQs
-
Who is Atul Varadhachary Ph.D?
Dr. Atul Varadhachary serves as Chief Executive Officer & Board Member at Radiomer Therapeutics.
-
How much does Atul Varadhachary Ph.D typically invest?
Atul Varadhachary Ph.D's median deal size is
. -
What is Atul Varadhachary Ph.D’s main position?
Atul Varadhachary Ph.D’s primary position is Chief Executive Officer & Board Member.
-
What are the contact details for Atul Varadhachary Ph.D?
Atul Varadhachary Ph.D’s email address is av
and his phone number is +1 (832) . -
How many active board seats does Atul Varadhachary Ph.D hold?
Atul Varadhachary Ph.D holds 5 board seats including Brevitest, Brimstalt Therapeutics, Fannin Innovation Studio, Goldenrod Therapeutics, and Radiomer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »